Mechanisms of urinary protein excretion in the pregnant women with preeclampsia

Mechanisms of urinary protein excretion in the pregnant women with preeclampsia - Mechanisms of urinary protein excretion in the pregnant women with preeclampsia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047875

Enrollment

100

Registered

2022-05-31

Start date

2022-05-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant women with preeclampsia with proteinuria pregnant women with gestational hypertension uncomplicated pregnant women

Exclusion criteria

Exclusion criteria: None of the participants smoked, consumed alcohol or caffeine, or had a history of thyroid disease, hypertension, diabetes mellitus, hyperlipidemia, or liver disease and were not taking any medications known to influence lipoprotein metabolism.

Design outcomes

Primary

Measure	Time frame
We assess urinary albumin and serum hyaluronan (HA) as glycocalyx disability, podocalyxine as podocyte disability, and urinary NAG, and L-FABP as renal tubule disability.	—

Countries

Japan

Contacts

Public ContactKazushi Watanabe

Aichi Medical University Obstetrics and Gynecology

kw446433@aichi-med-u.ac.jp+81-561-62-3311

Outcome results